Who owns mounjaro drug?

Who owns Mounjaro (tirzepatide)?

Mounjaro is owned by Eli Lilly and Company. Eli Lilly markets tirzepatide as Mounjaro and holds the related brand rights.

Who makes tirzepatide if it’s not Mounjaro?

Tirzepatide is the active ingredient in Mounjaro and is manufactured and sold under Eli Lilly’s direction as the Mounjaro brand. Other companies generally sell products only if they have their own approved medicines (such as biosimilars where applicable) and the necessary regulatory clearances.

Does patent or exclusivity ownership work differently from brand ownership?

Yes. Brand ownership (who markets Mounjaro) and patent/exclusivity ownership (who controls rights to manufacturing and sale) often both point to the same company for a given product, but the legal rights can differ by jurisdiction and by specific patents. Patent status and assignees are tracked through patent databases; DrugPatentWatch.com is one place to check relevant patent records for Mounjaro.

Sources:
1. DrugPatentWatch.com – Mounjaro (tirzepatide) patents